Table 3.

Genes with over 50% of the promoter region CpG sites having higher methylation in tumor tissue from prostate cancer patients with recurrence versus no recurrence

Candidate gene	Illumina CpG site	Avg. β value: recurrence	Avg. β value: no recurrence	P^a	CpG location	Third IQR
ABHD9	cg18366919	0.581264	0.522453	0.000295	Island	0.649
ABHD9	cg26010734	0.507842	0.442909	0.000385	N_Shore	0.565
ABHD9	cg17476026	0.429670	0.357897	0.000540	N_Shore	0.525
ABHD9	cg17399362	0.512639	0.432249	0.000838	N_Shore	0.614
ABHD9	cg08457898	0.569149	0.518281	0.001475	N_Shore	0.643
ABHD9	cg16184495	0.589635	0.530117	0.001796	N_Shore	0.672
ABHD9	cg15826897	0.483290	0.434591	0.002572	N_Shore	0.535
HOXD3	cg13316854	0.438143	0.364137	9.46E-06	Island	0.476
HOXD3	cg24704177	0.453488	0.377573	2.93E-05	Island	0.498
HOXD3	cg06145336	0.671013	0.594325	3.33E-05	Island	0.742
HOXD3	cg01014615	0.646853	0.575173	9.87E-05	Island	0.719
HOXD3	cg12634591	0.488850	0.419412	0.000159	N_Shore	0.538
HOXD3	cg09387749	0.646414	0.581765	0.000419	N_Shore	0.715
HOXD3	cg25938806	0.456353	0.391304	0.000618	N_Shore	0.502
HOXD3	cg02773086	0.623405	0.569983	0.001001	N_Shore	0.691
HOXD3	cg18702197	0.426674	0.362498	0.001237	Island	0.472

Abbreviation: IQR, interquartile range.

↵^aP values with Bonferroni correction for multiple testing within each gene.